Variables | ARBs | ACE inhibitors | ||
---|---|---|---|---|
OR | 95% CI | OR | 95% CI | |
Patient gender | ||||
Female (reference) | 1.00 | - | 1.00 | - |
Male | 0.99 | 0.94–1.05 | 1.07 | 1.03–1.11 |
Patient age (years) | ||||
30–54 (reference) | 1.00 | - | 1.00 | - |
≥55 | 0.74 | 0.70–0.78 | 0.75 | 0.72–0.78 |
Geographical region | ||||
Northwest (reference) | 1.00 | - | 1.00 | - |
Midwest | 0.74 | 0.68–0.80 | 0.98 | 0.93–1.02 |
Southwest | 0.67 | 0.62–0.72 | 0.86 | 0.82–0.90 |
Eastern | 1.34 | 1.19–1.52 | 1.39 | 1.29–1.49 |
Offshore islands | 2.78 | 2.21–3.49 | 0.45 | 0.35–0.57 |
Type of clinical facility | ||||
Primary care clinics (reference) | 1.00 | - | 1.00 | - |
Local hospitals | 2.17 | 1.98–2.38 | 0.43 | 0.41–0.45 |
Regional hospitals | 3.55 | 3.26–3.87 | 0.52 | 0.49–0.55 |
Medical centers | 5.77 | 5.32–6.25 | 0.63 | 0.60–0.66 |
Time elapsed since initial therapy | ||||
1 year or less (reference) | 1.00 | - | 1.00 | - |
2–3 years | 1.00 | 0.92–1.09 | 0.93 | 0.89–0.97 |
4–7 years | 1.12 | 1.03–1.21 | 0.95 | 0.90–1.00 |
Comorbidity after hypertension† | ||||
Diabetes mellitus | 1.55 | 1.42–1.68 | 1.36 | 1.28–1.44 |
Ischemic heart disease | 1.10 | 1.02–1.19 | 0.78 | 0.73–0.82 |
Stroke | 1.02 | 0.93–1.11 | 0.98 | 0.91–1.05 |
Chronic renal disease | 1.07 | 0.94–1.22 | 0.92 | 0.83–1.02 |
Calendar years | ||||
1998–2000 (reference) | 1.00 | - | 1.00 | - |
2001–2002 | 2.35 | 2.12–2.62 | 0.87 | 0.83–0.91 |
2003–2004 | 4.45 | 4.01–4.94 | 0.79 | 0.75–0.83 |